logo
Select company
Select metric
$ -2.37MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
40
Sector
45
Industry
48
History
43
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information

Ticker

ERNA

Company Name

ERNEXA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ERNEXA THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ERNA - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -2.37M
3/31/2025$ -7.29M
12/31/2024$ -9.94M
9/30/2024$ -4.38M
6/30/2024$ 749K
3/31/2024$ -281K
12/31/2023$ -3.87M
9/30/2023$ -4.61M
6/30/2023$ -13.47M
3/31/2023$ -14.01M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -1.07M.
  • Over the past 5 years, ERNEXA THERAPEUTICS INC's average CF - Chg. Cash has been $ -111.75K.
  • The median CF - Chg. Cash for ERNEXA THERAPEUTICS INC during this period was $ -2.5M
  • ERNEXA THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 46.88M.
  • The lowest CF - Chg. Cash recorded by ERNEXA THERAPEUTICS INC in the same timeframe $ -30.76M

ERNEXA THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
BRTX : BIORESTORATIVE THERAPIES INC $ -697KVYNE : VYNE THERAPEUTICS INC $ -7.61MIBIO : IBIO INC $ -5.63MLEXX : LEXARIA BIOSCIENCE CORP $ -3.87MLYRA : LYRA THERAPEUTICS INC $ -2.12MPULM : PULMATRIX INC $ -8.02MAPRE : APREA THERAPEUTICS INC $ -12.17MHCWB : HCW BIOLOGICS INC $ 1.28MMGRX : MANGOCEUTICALS INC $ -388.36KPHIO : PHIO PHARMACEUTICALS CORP $ 6.08M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

ERNA - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -30.76M

Minimum

Jun 30, 2022

$ 46.88M

Maximum

Jun 30, 2021

$ -111.75K

Average

$ -2.5M

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M